Open AccessDiuretics and β-Blockers Do Not Have Adverse Effects at 1 Year on Plasma Lipid and Lipoprotein Profiles in Men With Hypertension
Author(s) -
Raj Lakshman,
Domenic J. Reda,
Barry J. Materson,
William C. Cushman,
Edward D. Freis
Publication year - 1999
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.159.6.551
Subject(s) - hydrochlorothiazide , placebo , medicine , atenolol , endocrinology , adverse effect , carvedilol , chlorthalidone , apolipoprotein b , lipoprotein , irbesartan , prazosin , cholesterol , pharmacology , diuretic , blood pressure , antagonist , heart failure , alternative medicine , receptor , pathology
Concern based on the reported short-term adverse effects of antihypertensive agents on plasma lipid and lipoprotein profiles (PLPPs) has complicated the therapy for hypertension.